Articles related to IMAGING/SCREENING

New research questions the life-extending efficacy of most common cancer screenings, emphasizing the need for transparent physician-patient discussions to weigh the risks and benefits. Learn more about this crucial topic that might change your approach to recommending screenings.

Explore the complexities and challenges that could arise for oncologists with the potential expansion of blood biopsy insurance coverage through the MCED Screening Coverage Act.

This retrospective cohort study provides a detailed analysis of overdiagnosis in breast cancer screening among women aged 70 and above. Physicians are encouraged to explore the findings to better understand the implications of screening practices for older women.

The ACP’s updated guidance on CRC screening highlights the significance of starting at age 50 and underscores the importance of shared decision-making in selecting appropriate screening methods.

As we continue to improve the sensitivity of breast imaging, the need for surgical excision of benign proliferative lesions diagnosed on core needle biopsy remains a contentious topic, calling for careful examination of acceptable excision thresholds, patient preferences, and potential disparities in care.

Unveiling USPSTF’s New Recommendation for Breast Cancer Screenings The US Preventive Services Task Force (USPSTF) has issued a notable change in breast cancer screening guidelines, shedding light on the growing concern of breast cancer morbidity in the United States. This recommendation has profound implications for early detection and potential reduction in mortality rates.